CO2016005763A1 - Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide - Google Patents
Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxideInfo
- Publication number
- CO2016005763A1 CO2016005763A1 CONC2016/0005763A CO2016005763A CO2016005763A1 CO 2016005763 A1 CO2016005763 A1 CO 2016005763A1 CO 2016005763 A CO2016005763 A CO 2016005763A CO 2016005763 A1 CO2016005763 A1 CO 2016005763A1
- Authority
- CO
- Colombia
- Prior art keywords
- ultraviolet
- cerium oxide
- nanoparticulate
- radiation
- mineral composition
- Prior art date
Links
Landscapes
- Cosmetics (AREA)
Abstract
La presente solicitud se relaciona con formulaciones para el cuidado o la protección de la piel contra la radiación ultravioleta, las cuales tienen como ingrediente principal óxido de cerio no nanoparticulado que no dejan residuos visibles sobre la piel, en otras palabras no se genera un tono blancuzco causado por la presencia de óxidos como el de cinc o el de titanio; donde la composición de acuerdo con la presente invención, comprende óxido de cerio que no ha sido tratado hasta reducir su tamaño de partícula a una escala manométrica y el óxido de cerio no es nanoparticulado antes de ser incorporado a la formulación, sino que forma una emulsión cuya composición presenta una estructura que corresponde a cristales líquidos.The present application relates to formulations for the care or protection of the skin against ultraviolet radiation, which have as its main ingredient non-nanoparticulate cerium oxide that does not leave visible residues on the skin, in other words a whitish tone is not generated caused by the presence of oxides such as zinc or titanium; wherein the composition according to the present invention comprises cerium oxide that has not been treated until its particle size is reduced to a manometric scale and cerium oxide is not nanoparticulate before being incorporated into the formulation, but forms an emulsion whose composition has a structure that corresponds to liquid crystals.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CONC2016/0005763A CO2016005763A1 (en) | 2016-12-26 | 2016-12-26 | Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CONC2016/0005763A CO2016005763A1 (en) | 2016-12-26 | 2016-12-26 | Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2016005763A1 true CO2016005763A1 (en) | 2018-01-05 |
Family
ID=62596888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2016/0005763A CO2016005763A1 (en) | 2016-12-26 | 2016-12-26 | Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide |
Country Status (1)
Country | Link |
---|---|
CO (1) | CO2016005763A1 (en) |
-
2016
- 2016-12-26 CO CONC2016/0005763A patent/CO2016005763A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019003264A1 (en) | Formulations for vaccines against neoplasia and methods for preparing the same. (divisional request 201703151) | |
CY1124592T1 (en) | 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES HERBICIDIC ACTIVE FORMULATED FROM TETRAHYDRO- AND DIHYDROFURANCARBOXYLIC ACIDS AND ESTERS | |
SV2017005461A (en) | BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO | |
BR122021018243A8 (en) | LOW PH TOPICAL COMPOSITION AND METHOD TO INCREASE THE TOPICAL APPLICATION OF A COSMETICALLY ACCEPTABLE ACTIVE INGREDIENT | |
CL2016002276A1 (en) | Topical compositions comprising an extract of coriolus versicolor to increase autoimmunity | |
WO2016007629A3 (en) | Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations | |
BR112018005905A2 (en) | ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound? | |
BR112016004358A8 (en) | pharmaceutical combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases, pharmaceutical composition, their uses, and kit | |
EA201590730A1 (en) | METHOD AND STEROID COMPOSITION FOR LOCAL APPLICATION | |
CL2019003572A1 (en) | Low-dose brimonidine combinations and uses thereof. | |
CL2015002513A1 (en) | Acellular vaccine against pertussis | |
CL2016001019A1 (en) | Compositions and procedures for the treatment of dental hypersensitivity | |
PH12018502110A1 (en) | A cosmetic composition | |
MX2022001404A (en) | Liquid dressing compositions and their veterinary uses. | |
AR101581A1 (en) | COLUTORY COMPOSITION | |
ES2895910T3 (en) | Multiphase compositions | |
SA521420975B1 (en) | Nanostructured Formulations for The Delivery of Silibinin and Other Active Ingredients for Treating Ocular Diseases | |
BR112015021640A2 (en) | photoprotective personal care composition, method for providing enhanced skin spf and use of a | |
MX2018005786A (en) | Novel formulations. | |
ES2514140B1 (en) | Use of the STX64 steroid sulfatase inhibitor for the treatment of aging | |
CO2016005763A1 (en) | Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide | |
CL2020001738A1 (en) | Percutaneous absorption preparation for the treatment of dementia containing donepezil. | |
CL2020000551A1 (en) | Formulation for topical use for the control and prevention of parasites in animals. | |
CL2021001655A1 (en) | Antimicrobial compositions comprising modified clay and biphenol. | |
SV2016005308A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALOPATHIES RELATED TO PAIN, USING AS ACTIVE AGENT TO KETOROLACO TROMETAMINE AND TRAMADOL CHLORHYDRATE |